Although HAT1 can promote PCa and CRPC progression through upregulating AR (including AR‐V7) expression via a BRD4‐mediated pathway and knockdown of HAT1 partially re‐sensitizes CRPC cells to ENZ treatment, there are still some problems to be further studied. The gene discussed is BRD4; the disease is posterior cortical atrophy.